NEW YORK (GenomeWeb News) – America's Choice Provider Network will now cover CombiMatrix's diagnostic laboratory services, CombiMatrix said today.
ACPN is a San Diego-based company that facilitates out-of-network services for more than 540 payers in the US, reaching about 14 million people. Under the new agreement, individuals whose healthcare providers liaise with ACPN will now have access to CombiMatrix's menu of chromosomal microarray-based prenatal, pediatric, and cancer cytogenetic testing services.
In addition to CMA, Irvine, Calif.-based CombiMatrix also offers fluorescence in situ hybridization, PCR and G-band chromosome analyses.
The firm, which saw its third quarter revenues rise 15 percent on increased prenatal testing volumes, has announced a number of payor agreements this year. Earlier this month, it announced a deal with Blue Cross and Blue Shield of Kansas City. In October, CombiMatrix said it had reached a deal with Three Rivers Provider Network, and during the summer it inked an agreement with Blue Shield of California.